Cargando…
Environmental impacts of mass drug administration programs: exposures, risks, and mitigation of antimicrobial resistance
Mass drug administration (MDA) of antimicrobials has shown promise in the reduction and potential elimination of a variety of neglected tropical diseases (NTDs). However, with antimicrobial resistance (AMR) becoming a global crisis, the risks posed by widespread antimicrobial use need to be evaluate...
Autores principales: | Konopka, Joanna K., Chatterjee, Pranab, LaMontagne, Connor, Brown, Joe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243877/ https://www.ncbi.nlm.nih.gov/pubmed/35773680 http://dx.doi.org/10.1186/s40249-022-01000-z |
Ejemplares similares
-
Uses of mathematical modeling to estimate the impact of mass drug administration of antibiotics on antimicrobial resistance within and between communities
por: Olesen, Scott W.
Publicado: (2022) -
The impact of mass drug administration of antibiotics on the gut microbiota of target populations
por: Gough, Ethan K.
Publicado: (2022) -
Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks
por: Rolfe, Robert J., et al.
Publicado: (2022) -
Empowering local research ethics review of antibacterial mass administration research
por: Sewankambo, Nelson K., et al.
Publicado: (2022) -
Efforts to mitigate the economic impact of the COVID-19 pandemic: potential entry points for neglected tropical diseases
por: Ehrenberg, John P., et al.
Publicado: (2021)